遗传多态性和抗结核治疗的不良反应
Hannah M Gunter1, Phuti Choshi2, Tafadzwa Chimbetete2
1Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
Pharmacogenomics
|June 20, 2025
概括
在结核病治疗中,预防药物不良反应 (ADR) 是至关重要的. 药物遗传学测试可以帮助优化药物治疗方案并降低风险,但其对结核病的临床实施是有限的.
科学领域:
- 药物基因组学 药物基因组学
- 传染性疾病 传染性疾病
- 临床药理学 临床药理学
背景情况:
- 结核病 (TB) 仍然是全球主要的传染性死亡原因,特别是在低收入和中等收入国家.
- 有效的结核病治疗需要长时间的多药疗法,增加药物不良反应 (ADR) 的风险.
- 耐多药结核病需要开发新的药物,进一步复杂化治疗策略和ADR管理.
研究的目的:
- 审查与结核病药物相关的主要限制治疗的副作用.
- 探索当前对药物代谢,ADR病理生理学和结核病药物的药物遗传风险因素的理解.
- 确定结核病治疗中药物遗传检测的研究缺口和实施障碍.
主要方法:
- 文献综述侧重于结核病药物不良反应,药理学和药物遗传学.
- 对药物代谢途径和ADR病理生理学的当前知识的分析.
- 鉴定已知与结核病药物毒性相关的药物遗传风险等位基因.
主要成果:
- 对于当前和新兴的结核病药物,存在显著的治疗限制的副作用.
- 对药物代谢和ADR病理生理学的理解正在进步,揭示了潜在的药物遗传影响.
- 已经确定了几种药物遗传风险等位基因,但它们在结核病中的临床应用是最小的.
结论:
- 药物遗传测试对优化结核病治疗方案和预防ADR具有前景.
- 显著的障碍阻碍了药物基因组学在结核病治疗中的临床实施.
- 需要进一步的研究和战略实施,以利用药物遗传学改善结核病患者的治疗结果.
相关概念视频
01:29Pulmonary Tuberculosis I
335
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
335
01:28Pulmonary Tuberculosis V
249
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
249
01:31Pulmonary Tuberculosis III
458
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
458
01:26Pulmonary Tuberculosis IV
209
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
209
01:28Pulmonary Tuberculosis II
387
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
387
01:21Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K